Improving schizophrenia diagnosis through biomarkers: An upcoming prospect

Journal of the Pakistan Medical Association

Volumn 60, Issue 7, 2010, Pages 595-596

  Zaidi, Syed Mohammad Asad ^a   Bikak, Abdul Latif ^a   Rameez ul Hassan, ^b  

^a Medical College   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DYSBINDIN; GLYCINE; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID; NEU DIFFERENTIATION FACTOR; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA;

DISEASE MARKER; DNA METHYLATION; EARLY DIAGNOSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FUNCTION; GENETIC DISORDER; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MENTAL HEALTH SERVICE; NERVE CELL GROWTH; NEUROIMAGING; NEUROMODULATION; NEUROPSYCHIATRY; PAKISTAN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ARTICLE; GENETIC MARKER; GENETICS;

BIOLOGICAL MARKERS; GENETIC MARKERS; HUMANS; SCHIZOPHRENIA;

EID: 77954466335     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Naqvi HA. Schizophrenia: a concept. J Pak Med Assoc 2008; 58: 133-7.
2. Burmeister M, McInnis MG, Zöllner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008; 9: 527-40.
3. Sullivan PF. The genetics of schizophrenia. PLoS Med 2005; 2: e212.
4. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-92.
5. Roberts RC. Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr Bull 2007; 33: 11-5.
6. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. The dystrobrevinbinding protein 1 gene: features and networks. Mol Psychiatry 2009; 14: 18-29.
7. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006; 15: 1995- 2002.
8. Neeman G, Blanaru M, Bloch B, Kremer I, Ermilov M, Javitt DC, et al. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. Am J Psychiatry 2005; 162: 1738-40.
9. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52: 998-1007.
10. Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol 2004; 14: 267-73.
11. Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett 2007; 420: 45-8.
12. Song XQ, Lv LX, Li WQ, Hao YH, Zhao JP. The interaction of nuclear factorkappa B and cytokines is associated with schizophrenia. Biol Psychiatry 2009; 65: 481-8.
13. Iwata Y, Suzuki K, Nakamura K, Matsuzaki H, Sekine Y, Tsuchiya KJ, et al. Increased levels of serum soluble L-selectin in unmedicated patients with schizophrenia. Schizophr Res 2007; 89: 154-60.
14. Zhang HX, Zhao JP, Lv LX, Li WQ, Xu L, Ouyang X, et al. Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia. Neurosci Lett 2008; 438: 1-5.
15. Capote HA. Neuroimaging in psychiatry. Neurol Clin 2009; 27: 237-49.
16. Saeed K, Gater R, Hussain A, Mubbashar M. The prevalence, classification and treatment of mental disorders among attendees of native faith healers in rural Pakistan. Social Psychiatry & Psychiatric Epidemiology 2001; 35: 480-5.